{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0000748592","name":"Ernexa Therapeutics Inc.","summary":"Ernexa Therapeutics Inc. is a preclinical-stage synthetic allogeneic iMSC (iPSC-derived mesenchymal stem cell) therapy company. Its lead candidate, ERNA-101, consists of IL-7 and IL-15-secreting iMSCs designed to target platinum-resistant ovarian cancer by delivering pro-inflammatory factors to the tumor microenvironment. A second candidate, ERNA-201, targets autoimmune disorders such as rheumatoid arthritis. The company in-licenses its core technology from Factor Bioscience Limited and collaborates with MD Anderson Cancer Center.","people":[],"products":[{"name":"ERNA-101","type":"platform","description":"Allogeneic IL-7 and IL-15-secreting iMSCs targeting platinum-resistant ovarian cancer via tumor microenvironment delivery."},{"name":"ERNA-201","type":"platform","description":"Anti-inflammatory cytokine (IL-10)-secreting iMSCs for autoimmune disorders such as rheumatoid arthritis."}],"partnerships":[{"partner_name":"Factor Bioscience Limited","partnership_type":"licensing","description":"Exclusive License and Collaboration Agreement for iMSC technology in cancer, autoimmune, and rare disease fields, signed September 2024.","start_date":null},{"partner_name":"University of Texas MD Anderson Cancer Center","partnership_type":"development","description":"Collaboration to investigate ERNA-101's ability to induce and modulate antitumor immunity in an ovarian cancer model.","start_date":null},{"partner_name":"Japan External Trade Organization","partnership_type":"strategic","description":"Accepted into JETRO acceleration program for expert mentoring, market-entry guidance, and engagement with Japanese R&D organizations.","start_date":null}],"affiliations":[],"origin":{"leaf":"11c1a5aaa3b9a5f4c97c287b42c362ae8d90073d8ca2d9f89ce9e4ad28812aa3","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"694740a7ba6aacf84ca4196106124d7bb6b00a1b2c0df7b425ecccdddaa8d8c9","parent":"41f3d3320e4247c91f59577d39c2ceae58234a037078fc7d448ce6364dc90cfc","source":"0001493152-26-010102","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":90,"hourly_limit":500,"remaining":410,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}